BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35852016)

  • 1. The 28th Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Soule HR
    Prostate; 2022 Oct; 82(14):1346-1377. PubMed ID: 35852016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 29th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2024 Feb; 84(2):113-130. PubMed ID: 37915138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 27th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2021 Nov; 81(15):1107-1124. PubMed ID: 34469608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2021 Jan; 81(1):3-19. PubMed ID: 33085787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 24th Annual Prostate Cancer Foundation scientific retreat report.
    Miyahira AK; Soule HR
    Prostate; 2018 Sep; 78(12):867-878. PubMed ID: 29761524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 22nd annual prostate cancer foundation scientific retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2016 Sep; 76(12):1037-52. PubMed ID: 27272144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 25th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2019 Sep; 79(12):1471-1486. PubMed ID: 31334865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Soule HR
    Prostate; 2017 Jul; 77(10):1093-1106. PubMed ID: 28503903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Cheng HH; Abida W; Ellis L; Harshman LC; Spratt DE; Simons JW; Pienta KJ; Soule HR
    Prostate; 2017 Nov; 77(15):1478-1488. PubMed ID: 28925066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 21st Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2015 Aug; 75(11):1119-28. PubMed ID: 25893521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 19th annual Prostate Cancer Foundation scientific retreat.
    Walia G; Pienta KJ; Simons JW; Soule HR
    Cancer Res; 2013 Aug; 73(16):4988-91. PubMed ID: 23536559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Sharp A; Ellis L; Jones J; Kaochar S; Larman HB; Quigley DA; Ye H; Simons JW; Pienta KJ; Soule HR
    Prostate; 2020 Feb; 80(2):113-132. PubMed ID: 31825540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 20th Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2014 Jun; 74(8):811-9. PubMed ID: 24719035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.
    Miyahira AK; Hawley JE; Adelaiye-Ogala R; Calais J; Nappi L; Parikh R; Seibert TM; Wasmuth EV; Wei XX; Pienta KJ; Soule HR
    Prostate; 2023 Feb; 83(3):207-226. PubMed ID: 36443902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Den RB; Carlo MI; de Leeuw R; Hope TA; Karzai F; McKay RR; Salami SS; Simons JW; Pienta KJ; Soule HR
    Prostate; 2019 Feb; 79(3):244-258. PubMed ID: 30381857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 17th Annual Prostate Cancer Foundation scientific retreat: meeting report.
    Ericson KR; Simons JW; Soule HR
    Prostate; 2011 Nov; 71(15):1616-20. PubMed ID: 21394742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.
    Luo J; Attard G; Balk SP; Bevan C; Burnstein K; Cato L; Cherkasov A; De Bono JS; Dong Y; Gao AC; Gleave M; Heemers H; Kanayama M; Kittler R; Lang JM; Lee RJ; Logothetis CJ; Matusik R; Plymate S; Sawyers CL; Selth LA; Soule H; Tilley W; Weigel NL; Zoubeidi A; Dehm SM; Raj GV
    Eur Urol; 2018 May; 73(5):715-723. PubMed ID: 29258679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report.
    Rhodes KE; Simons JW; Soule HR
    Prostate; 2010 Jun; 70(8):916-20. PubMed ID: 20166134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of advanced and castration resistant prostate cancer.
    Gomella LG; Petrylak DP; Shayegan B
    Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.